The anesthetic management of patients with FXI deficiency has historically relied on conventional coagulation tests, particularly activated partial thromboplastin time (aPTT) and FXI activity levels. This evidence concerns the gene F11 and hyperinsulinemic hypoglycemia, familial, 4.